SRS Capital Advisors »

Heron Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2k 1.1k 1.99
2024-06-30 $3.8k 1.1k 3.50

More positions owned by SRS Capital Advisors

Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for SRS Capital Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Vanguard Group
BlackRock
BlackRock
Tejara Capital
State Street Corporation
D. E. Shaw & Co
Palisade Capital Management
Geode Capital Management
JW Asset Management
Clearline Capital
Renaissance Technologies
Orchard Capital Managment
Congress Park Capital
Tang Capital Management

View all funds holding Heron Therapeutics